$0.7310
-0.04-4.74%
At close: -
$0.7400
0.009001.23%
After Hours: 7:26 PM EDT
Comments
Loading...
Seres Therapeutics (NASDAQ:MCRB) Stock, Earnings Estimates, EPS, And Revenue
Seres Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 4
EPS Estimate
$-0.210
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$126.33M
Analyze the earnings history of Seres Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Seres Therapeutics (MCRB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-13 | $-0.33 | $-0.24 | -37.5 % |
| Q2 | 2024-08-13 | $-0.22 | $-0.27 | 18.5 % |
| Q1 | 2024-05-08 | $-0.27 | $-0.34 | 20.6 % |
| Q4 | 2024-03-05 | $-0.32 | $-0.50 | 36.0 % |
Seres Therapeutics (MCRB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2024-05-08 | $0 | $250.00K | -100.0 % |
| Q3 | 2023-11-02 | $310.00K | $1.87M | -83.4 % |
| Q2 | 2023-08-08 | $126.47M | $125.50M | 0.78 % |
| Q1 | 2023-05-09 | $-522.00K | $1.38M | -137.8 % |
FAQ
When is Seres Therapeutics (NASDAQ:MCRB) reporting earnings?
Seres Therapeutics (MCRB) is scheduled to report earnings on March 4, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Seres Therapeutics (NASDAQ:MCRB)?
The Actual EPS was $-0.33, which missed the estimate of $-0.24.
What were Seres Therapeutics’s (NASDAQ:MCRB) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.